chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Since vaccine have severe headaches, sensitivity to light, feeling lethargic, balance is off, headaches keep me up at night. I've seen my primary doctor, neurology, ophthalmology, and had an MRI,and an iv. I don't have insurance, and I've haven't been to work or been able to drive.  Doctor wants me to go to ER
baby found dead in crib;coroner ruled death from SIDS; (baby on water bed);
Pt woke this morning 2/12/2021 at 8:30 and he had swelling to his lips and rt side of face (cheek area), Pt reported at 3:30pm still noted lip swollen and rt cheek swollen but not as much as when he awoke at 8:30
Information has been received by a physician concerning a female who in 09/2003 was vaccinated with varicella virus vaccine, live. Subsequently, " in a couple of weeks" the child developed a peculiar rash on the buttocks. It was believed to  have been the same side in which the immunization was administered. The rash " reappeared about every two months" the pt was considered not to be recovered. Unspecified medical attention was sought. No product quality complaint involved. Additional information has been requested.
Tachycardia, tightness in throat, dizziness- given epinephrine by EMS
pt recvd vax 2JUN92 that evening eye pain devel; on 3JUN92 eye pain & grayness of vision; 5JUN92 blindness rt eye; permanent nerve damage;
Admit for COVID pneumonia. Vaccine completed Feb or Mar 2021. Treated w/ O2, remdesivir, steroids, Rocephin, azithromycin. Discharged home.
Patient was light-headed, dizzy, and pale minutes after receiving the vaccine. They also reported difficulty seeing (their field of vision was all bright light.)
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. No information on the patient's concomitant medications, concurrent conditions, pertinent medical history, drug reactions or allergies was reported. On an unspecified date in approximately 2015 (reported as "approximately one year ago"), the patient was vaccinated with the first dose of ZOSTAVAX (dose, route of administration, lot # and expiration date were not reported). On an unspecified date, after the first dose administration, the patient was vaccinated with the second dose of ZOSTAVAX (dose, route of administration, lot # and expiration date were not reported). No adverse symptoms were reported. Additional information has been requested.
At about 1:15 PM, 6 hours after receiving the first dose of the vaccine, I experienced an episode of Raynauds phenomenon in my left hand, 2nd through 5th finger. It took 20 minutes of active warming (rubbing, external heat) to resolve this episode. Then 20 minutes later I had another episode of Raynauds, more severe with bilateral hand involvement, fingers 2-5 on both hands. The second episode took 15-18 minutes of active warming to resolve. After these two episodes I started feeling very fatigued which I had not felt prior to the episodes.
Systemic: Patient got really sweaty about an hour after the vaccine.  Blood pressure was elivated and patient reported mild SOB.-Medium
This spontaneous report has been received from an 85 year old female consumer reporting on herself. The patient's concurrent conditions including hypertension and emphysema using oxygen and nebulizer. As past medical history the patient had a drug reaction of rash. On an unspecified date, the patient was vaccinated with the first dose of ZOSTAVAX (strength, dose, route, anatomical location, lot # and expiration date unspecified by the reporter). On an unspecified date in December 2015 the patient was vaccinated with a second shot of ZOSTAVAX (strength, dose, route, anatomical location, lot # and expiration date not provided). Concomitant therapies included aspirin and high blood pressure medicine (unspecified). On approximately 10-DEC-2015 (reported as 3 weeks ago) the patient developed shingles after receiving the second dose of ZOSTAVAX. It was described as a rash that would move on body; the patient reported that it would itch and burn like hell. Patient sought for medical attention and was seen by a physician. She was prescribed with VALTREX 3 times daily and hydrocortisone cream. The patient stated that the physician told her that it might take a long time to heal. The patient reported, that the pharmacist contacted her to see, if she wanted to received a third dose of ZOSTAVAX but the physician stated that he would not recommend to get an additional dose. At the time of the report the outcome of shingles was reported not recovered, although the shingles improved on prescribed therapy, the relatedness between the events and the suspect therapy was not reported. Additional information has been requested.
Got Vaccine on his left side and then feeling sore, like it hurts on his chest; This is a spontaneous report from a contactable consumer. This contactable consumer (Parent) reported for a male patient (reporter's son) of an unspecified age that he received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: FC3181, NDC Number, UPC Number, Expiry Date: Unknown), via an unspecified route of administration on Aug2021 as dose number unknown, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient got vaccine on his left side and then feeling sore, like it hurts on his chest on Aug2021. Reporter had a question, about the patient that he got Pfizer Covid vaccine 2 days ago on his left side and then he felt sore like it hurts on his (chest). The reporter wanted to know whether it was normal or not. Reporter stated that not on his hand, it hurts like on his chest. The outcome of event was unknown.  This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected."
diarrhea that lasted until 06Mar2021 and ended with bleeding.; This is a spontaneous report received from a Pfizer sponsor program via Medical information team. A contactable consumer (patient) reported that a female patient of an unspecified age received the first dose of bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and Expiration date was not reported), via an unspecified route of administration on 25Feb2021 as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Patient mentioned that on 28Feb2021 she experienced diarrhea that lasted until 06Mar2021 and ended with bleeding on an unspecified date in 2021. Patient was asking if this can be related to the vaccine. Patient received first Covid vaccine on 25Feb2021 Second dose is Scheduled four weeks later on 25Mar2021. The outcome of the event was unknown.  Information on the lot/batch number has been requested.
tested positive for covid; Initial information received on 30-May-2023 regarding an unsolicited valid  non-serious case received from a pharmacist.  This case involves an unknown age and unknown gender patient who experienced tested positive for covid while receiving vaccine Rabies (Hdc) Vaccine [Imovax Rabies].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose 1 of suspect Rabies (Hdc) Vaccine, Powder and solvent for suspension for injection, dose: 0.5 ml (lot number, expiry date: not reported) (strength: unknown) via unknown route in unknown administration site for immunisation.  "Information on the batch number was requested."  On an unknown date the patient tested positive for covid (covid-19) (unknown latency) following the administration of Rabies (Hdc) Vaccine.  It was reported, "Pharmacist is asking about IMOVAX. 2 doses is required. The patient received the first shot and then tested positive for COVID. What is the recommendation now for the 2nd shot? Pharmacist inquiring about the 2nd administration of IMOVAX to a patient who has tested positive for Covid." First time product used : No Still using product : Yes.  Relevant laboratory test results included: SARS-CoV-2 test - On an unknown date: Positive  Action taken with Rabies Vaccine was not applicable.  It was not reported if the patient received a corrective treatment for the event.  At time of reporting, the outcome was Unknown for the event.
24 hours after vaccination I had tingling and numbness on right side of face, heavy eyelids, "pulling sensation" in neck. Unable to lay flat.  Tingling and numbness would switch from right side to entire face but mostly on right side.  Headaches and noticed increased heart rate two days after vaccine. One week after vaccine numbness and weakness extended down right arm and leg, able to move leg just felt "weak".  I thought I was having a stroke or TIA. Made an appt. with the NP and she did full neuro exam and everything came back normal.  Also, made an appt. with my PCP.  Still continued to have headaches and weakness improved. Did get a COVID test since was still having headaches and it so long since vaccine, received test 1/12/2021 and it was negative. This past weekend was the 1st time I felt "pre vaccine" 17 days post vaccination. I am truly hesitant to take my 2nd dose scheduled on 1/26/2021.
I received my booster shot today but I was previously told that the shot should be 50mcg and she gave 25mcg; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSAGE FORM CONFUSION (I received my booster shot today but I was previously told that the shot should be 50mcg and she gave 25mcg) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 25 mcg. On 03-Nov-2021, the patient experienced PRODUCT DOSAGE FORM CONFUSION (I received my booster shot today but I was previously told that the shot should be 50mcg and she gave 25mcg). On 03-Nov-2021, PRODUCT DOSAGE FORM CONFUSION (I received my booster shot today but I was previously told that the shot should be 50mcg and she gave 25mcg) had resolved.            Concomitant medication use was unknown Treatment information was unknown
Moderna #1 vaccine given at 130pm March 11th 2021. Pt had history of asthma and frequent nebulizer use and had it in car with her for drive-thru vaccine clinic we did at location, which has a large parking lot. We gave 80 doses. Pt checked off anaphylaxis on the intake form so Dr spoke to her and she changed it to no history of anaphylaxis and only has history of asthma. So we gave her the vaccine. About 5 minutes later in car parking lot she started to use her personal nebulizer. I saw her in passenger side of car using a personal nebulizer so I talked to her and her daughter to find out what was going on. They said she has exacerbations all the time and this was not out of ordinary for her. I checked pulse ox and did a lung exam, etc, and she was stable.  She seemed baseline according to history by her and her daughter.  As she seemed at baseline and clinically was comfortable and conversant whole time, and she felt better after her nebulizer, I told them to have a low threshold for going to ER or calling 911 if her asthma was worse or different than her usual symptoms.  They agreed. According to daughter, she did well until about 24 hours the next day. The daughter said she was fine and she went to store and when she returned EMTs were intubating patient and apparently the patient used her epipen and called 911 herself. Approximate time of expiration was 230pm on March12th 2021.
pt up from chair p/vax given & fainted falling to the floor & hitting head on the floor;awoke was helped back onto the chair w/a lump forming on the lt forehead;ice was used for this;left clinic w/in 10min, alert, stating felt OK;v,sleepy;
About 2-3 minutes after receiving the vaccine patient started spitting up phlegm/vomiting. I did not witness as I left to get child a book. When I returned the child had already vomited up saliva she continued to vomit a few more times foamy and clear with some yellow bile. Mom mentioned patients arms looked red and there was a spot on her forehead that looked red.
No adverse effects; The patient was re vaccinated with ZOSTAVAX because the one she received in 2005 was under filled; The patient was re vaccinated with ZOSTAVAX because the one she received in 2005 was under filled; This spontaneous report was received from a female patient of unknown age concerning to herself. The patient's medical history, concomitant medications, drug reactions or allergies were not reported.  On an unspecified date in 2005, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) 19400 Plaque Forming Units (PFU) (dose, frequency, route of administration, anatomical location, lot # and expiration date were not provided) for prophylaxis, which was underfilled (product quality issue, incorrect dose administered). For this reason, the patient was told on an unspecified date in 2019, that she had to be re vaccinated with Zoster Vaccine Live (ZOSTAVAX). No adverse effects were reported. At the reporting time, the outcome of the product quality issue was unknown.    The causality between the event of product quality issue and Zoster Vaccine Live (ZOSTAVAX) was not reported.
This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 69-year-old female patient who received SHINGRIX for prophylaxis. On 14th August 2018, the patient received the 1st dose of SHINGRIX. On 15th August 2018, 1 days after receiving SHINGRIX, the patient experienced pain in arm. On 16th August 2018, the patient experienced chest burning and tingling. On 18th August 2018, the patient experienced numbness of upper extremities and fear. On an unknown date, the outcome of the pain in arm, chest burning, tingling, numbness of upper extremities and fear were recovered/resolved. It was unknown if the reporter considered the pain in arm, chest burning, tingling, numbness of upper extremities and fear to be related to SHINGRIX. Additional details were provided as follows: 2 days after vaccination, the patient experienced chest burning and tingling. On 17th August 2018, the patient was ok with no symptoms. On 18th August 2018, 4 days after vaccination, the patient experienced numbness of upper extremities, fear and went to emergency room. The patient did not want to provide her full name nor any details for the report. The reporter did not give consent to follow up. Customer declined to providing last name nor initials. This case was 1 of the 2 cases, reported by the same reporter.
p/vax mom reported child had fever up to 105.4 for several days;pt was eval @ clinic then to ER for high temp & eval only tx required was oral antipyretics, APAP, advil, motrin;
Soreness at injection site (nearly immediate) Muscle and joint aches, fever, fatigue
45 minutes after immunization, patient experienced right eyelid swelling and wheezing, requiring emergency anaphalaxis treatment.
Severe headache, chills, body aches, sore joints, extreme fatigue, weakness symptoms lasted 4 days-unable to go to work, also arm pain.
Information has been received from a physician referring to a 2 month old patient of unknown gender. Information about medical history, concurrent condition and concomitant medication was not reported. The patient was vaccinated with the first dose of RECOMBIVAX HB (strength, dosage and route unspecified) on 20-JUL-2015, the second dose of RECOMBIVAX HB (strength, dosage and route unspecified) on 21-AUG-2015 and the third dose of RECOMBIVAX HB (strength, dosage and route unspecified) on 21-SEP-2015 (inappropriate schedule of vaccine administration). No adverse symptoms were reported. Additional information has been requested.
Patient is fully vaccinated.  Tested + for COVID at ED visit on 4/15/2022. Patient presents to the ED secondary to a 5-day history of cough, nausea and vomiting, sore throat, subjective fevers and chills.Positive for headache and myalgias and weakness. Denies any chest pain.  No shortness of breath.  No abdominal pain.  No EKG changes. CXR: Minimal left basilar interstitial opacities correlates with history of Covid infection. Medications: fluids, zofran, cepacol. Discharged to home.
She had pain at the injection site and a sore arm; sore arm; This is a spontaneous report from a contactable consumer. This report was received via a sales representative. A 15-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose number unknown, single for covid-19 immunisation. Medical history and concomitant medications were not reported. The patient experienced pain at the injection site and a sore arm on an unspecified date after use of product. The outcome of events was unknown.   Information on the Lot/Batch number has been requested.
BLOOD CLOTS IN THE LEFT LUNG; SHORT IN BREATH/ BARELY BREATHING; MOVEMENT DISORDER (COULD NOT GET OUT OF THE CAR); CONFUSED; ZERO APPETITE; WEAKNESS AND ZERO ENERGY; This spontaneous report received from a parent (mother) concerned a 49 year old male. Initial information was processed with additional information received on 17-MAY-2021. The patient's weight was 200 pounds, and height was not reported. The patient's past medical history included asthma. He did not experience something like that for thirty years. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) frequency 1 total, dose was not reported, administered on 02-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  Patient  got the Janssen Covid 19 vaccine on 02-APR-2021, nothing happened no side effects at all ,he didn't experience anything abnormal. On 06-MAY-2021 (four weeks later),patient drove for 22 miles, he didn't get enough drinks, short in breath, he could not get out of the car (coded as movement disorder), he was in the car since 11.30 am in the morning, remained in the car till 12 PM at night, leaning against the kitchen sink, he was barely breathing. The reporter called the ambulance, they came and transported the patient to the medical center, they admitted him on 07-MAY-2021, and they did tests, and x-rays, they confirmed that he had blood clots in the left lung. The hospital was full, they couldn't find a room for patient then they admitted him in to a room on second floor. The patient had no medical issues or problem before the vaccine The patient  got out of the hospital on 12-MAY-2021 (Wednesday). Patient was hospitalized for 6 days. During follow-up, reporter mentioned that on an unspecified date in MAY-2021, her son was weak and confused ,zero appetite ,zero energy, he was not the same person he was two weeks ago, he was going to take medications indefinitely its like a life sentence for him, and she also did not have an email address. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from movement disorder (could not get out of the car), had not recovered from blood clots in the left lung, and short in breath/ barely breathing, and the outcome of weakness and zero energy, confused and zero appetite was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0.20210531244-covid-19 vaccine ad26.cov2.s -blood clots in the left lung, and short in breath ,weakness and zero energy, confused and zero appetite. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Around 9:15am She began complaining of epigastric/midsternal chest pain, non-radiating. She was not short  of breath or diaphoretic. She denied nausea but did heave and spit up clear fluid. She had elevated HR 131-86 during a 45minute time period and elevated blood pressure 165-135/90-103 during the same time period. She had what appeared to be a brief fainting spell and experienced some confusion.  She was transported to  ER/EMS at 10:47am. She was sent home from the ER later in the day.
Information has been received from a pharmacist concerning a 66 year old female with no allergies who on 05-JUN-2007 was vaccinated SC on right arm with a dose of Zostavax (Oka/Merck) (Lot # 652947/1411F). On 07-JUN-2007 the patient experienced severe pain under the right rib and nausea and was seen by her physician. The physician felt that the patient may be experiencing a "gallbladder attack" and the patient was sent to the hospital. The patient was admitted to the hospital and stayed overnight. A number of unspecified tests were conducted and a gallbladder attack was ruled out. The patient's symptoms resolved and the patient was discharged on 08-JUN-2007. The origin of the pain was unknown. At the time of report the patient had recovered. Unspecified medical attention was sought.  A product quality complaint was not involved. The patient's experiences were considered to be other important medical events by the reporter. Additional information has been requested.
Admission Date: 8/9/2022 Discharge Date: Aug 12, 2022  PRESENTING PROBLEM: Weakness Generalized weakness COVID-19   HOSPITAL COURSE: 87-year-old man who had a TAVR and pacemaker placement in June 2022 was recently discharged from the hospital 1 day ago.  He was hospitalized from 7/30/2022-8/8/2022 for Streptococcus bacteremia.  This was deemed secondary to a pocket of pacemaker pacemaker infection.  The TEE on that admission did not reveal any vegetations on the TAVR.  The pacemaker was revised with a leadless pacemaker on 08/05/2022.  He is placed on 2 g IV ceftriaxone to complete a 6 week therapy and follow-up with the ID team.  Was discharged on 08/08/2022.     Since the discharge patient felt very well.  He was mobile and active.  However last night he felt weak and has been coughing. He denies any chills. He felt like his temperature was up to 100° F. he denies shortness of breath chest pain palpitation. He is just so profoundly weak that he is not able to get out of bed and just staying in bed. His family brought him back chest x-ray in the emergency room did not show pneumonia. He is not needing any oxygen. His heart rate has been in 40s and pacemaker is not capturing. We adjusted pacer settings. Health center has reserved a Saturday morning TIMED NURSE Visit for patient to resume home antibiotic therapy support. Patient has all antibiotic supplies in the home, verified this information with patient's spouse. He will discharge home and follow up with PCP within one week.